IMEXHS signs a new global partnership agreement to license Vitrea® software by Vital Images, Inc.

Thanks to the IMEXHS-Vital Images collaboration, now the Vitrea® application suite will be available in the cloud through an affordable subscription-on-demand model, allowing IMEXHS customers to access their data, performing an advanced analysis and visualization processes, directly from its AQUILA platform.

“This is a significant agreement for IMEXHS and our full-service imaging capabilities.” “A global partnership with a company of Vital’s caliber energizes our ambitious growth plans into new markets and customer segments. We believe this is the first agreement in a long-term and mutually beneficial partnership.” Alejandro Varettoni, de IMEXHS´s Chief Sales Officer.

Vitrea® is an advanced 2D, 3D, and 4D visualization system that allows analyzing medical data from various modalities such as computed tomography, magnetic resonance spectroscopy, X-ray angiography, positron emission tomography, photon emission tomography, and ultrasound; improving diagnosis through its clinical tools.

Now, IMEXHS has integrated the full suite of cutting-edge Vitrea® tools so that users can enjoy optimized observation directly from their AQUILA platform, through an on-demand subscription model hosted in the Azure cloud.

This agreement also makes advanced visualization processing more efficient for physicians optimizing, and centralizing the method within the AQUILA platform while allowing them to take advantage of its superior teleradiology capabilities.

Based in the United States, Vital, recognized in the world market as a leader in the post-processing of medical images thanks to its diagnostic imaging solutions to several of the best hospitals in the world, is a Canon Medical Systems Corporation’s company, which has a legacy of leadership in healthcare imaging, using smart algorithms and innovation techniques for over 30 years.

The IMEXHS-Vital collaboration will undoubtedly significantly increase the organization’s global reach and further strengthen AQUILA’s value proposition among a wide range of healthcare institutions.